Compound 66
Identifiers
- Canonical SMILES:
FC(F)(F)Oc1ccc(Br)c2[nH]cc(C(=O)C(=O)N3CCN(CC3)C(=O)c3ccccc3)c12
- IUPAC name:
1-(4-benzoylpiperazin-1-yl)-2-[7-bromo-4-(trifluoromethoxy)-1H-indol-3-yl]ethane-1,2-dione
- InChi:
InChI=1S/C22H17BrF3N3O4/c23-15-6-7-16(33-22(24,25)26)17-14(12-27-18(15)17)19(30)21(32)29-10-8-28(9-11-29)20(31)13-4-2-1-3-5-13/h1-7,12,27H,8-11H2
- InChiKey:
AAQNOENKTHJXFV-UHFFFAOYSA-N
External links
506252 |
CHEMBL493838 |
442083 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.37 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 523.04 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 4.36 | |||
TPSA | 82.71 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6704 | BMS-488043 | DB05532 | |
0.6045 | Timcodar | DB12761 | |
0.5805 | Talmapimod | DB05412 | |
0.5775 | Melatonin | DB01065 | |
0.5461 | N-acetylserotonin | DB04275 | |
0.5389 | Varespladib | DB11909 | |
0.5337 | Oxypertine | DB13403 | |
0.5306 | Varespladib methyl | DB05737 | |
0.5282 | 5-Methoxy-N,N-diisopropyltryptamine | DB01441 | |
0.5250 | LY-517717 | DB05713 | |
0.5220 | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | DB08190 | |
0.5211 | Dipropyl-4-hydroxytryptamine | DB13990 | |
0.5196 | Piromelatine | DB12288 | |
0.5184 | Tadalafil | DB00820 | |
0.5160 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide | DB07981 |